Assert-IQ vs FFRct
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent in the cardiology AI space but serve distinct diagnostic purposes. Assert-IQ focuses on long-term, continuous monitoring for arrhythmia detection, aiding in the diagnosis and management of heart rhythm disorders. In contrast, FFRct is a non-invasive tool that analyzes CCTA scans to assess coronary artery blood flow and diagnose coronary artery disease.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Assert-IQ is designed for long-term, continuous monitoring and advanced arrhythmia detection to diagnose and manage patients with suspected heart rhythm disorders. FFRct, on the other hand, is a non-invasive diagnostic tool that creates personalized 3D models from CCTA scans to assess blood flow and aid in diagnosing coronary artery disease.
Assert-IQ involves the minimally invasive insertion of an Insertable Cardiac Monitor (ICM) for continuous cardiac monitoring. FFRct is entirely non-invasive, utilizing AI and computational fluid dynamics to analyze existing CCTA scans without any physical intervention.
Assert-IQ provides advanced arrhythmia detection algorithms, remote monitoring capabilities, and proactive clinician alerts based on continuous cardiac data. FFRct generates personalized 3D digital models of coronary arteries, analyzes blood flow, and identifies areas of narrowing (FFRct values) to help guide treatment strategies and revascularization decisions.
Assert-IQ primarily targets Cardiology and Internal Medicine specialists for arrhythmia detection and management. FFRct is aimed at Cardiology and Radiology specialists, assisting in the diagnosis and management of coronary artery disease.